13 July 2021 - NICE is quite far along a NICE led process to review its methods and processes for ...
13 January 2021 - NICE worked with patients and staff from six patient organisations to review existing health technology assessment ...
25 June 2020 - Having worked in the NHS as a hospital pharmacist before moving into market access roles in ...
2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
28 June 2019 - Including information and values from patients in HTA has the potential to improve both the process and ...
14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...
16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...
25 October 2017 - For medical devices, benefits other than direct clinical effects may have a large impact on the patients’ ...
25 October 2017 - The INTEGRATE-HTA project provided methodology to evaluate complex technologies. ...
25 September 2017 - Industry expert’s evidence is not independent, NICE argues. ...
8 April 2016 - The Department of Health has asked NICE to produce guidance on the use of azacitidine in the ...
4 April 2016 - The Department of Health has asked NICE to produce guidance on using mepolizumab in the NHS in ...
4 January 2016 - Every two months the NICE Board holds its meeting in a different venue; moving from region to ...
24 November 2015 - The draft guidance gives provisional recommendations on whether paclitaxel, pegylated liposomal doxorubicin hydrochloride, topotecan hydrochloride, trabectedin and ...